Skip to main content
. 2011 May 19;6(5):e20372. doi: 10.1371/journal.pone.0020372

Table 2. Select Substrates of OATPs[3], [21].

Substrate
OATP1B1
Anti-Cancer Drugs ACU-154
antamanide
Bamet-R2
Bamet-UD2
demethyl phalloidin
dihydromicrocystin-LR
irinotecan
ketoconazole
methotrexate
paclitaxel
PKI-166
SN-38
Hormones estrone-3-sulfate
estradiol-17B-glucuronide
prostaglandin E2
thyroxine (T4)
triiodothyronine (T3)
OATP1B3
Anti-Cancer Drugs demethylphalloin
dihydromicrocystin-LR
docetaxel
imatinib
irinotecan
methotrexate
paclitaxel
SN-38
Hormones DHEAS
testosterone
estrone-3-sulfate
estradiol-17B-glucuronide
thyroxine (T4)
triiodothyronine (T3)
OATP2B1
Anti-Cancer Drugs unknown
Hormones DHEAS
estrone-3-sulfate
pregnenolone sulfate
prostaglandin E2